Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Niklas Carlén to Leave is Position as CFO of Stille

Stille
Download the release

Stille AB (publ) informs that Niklas Carlén has decided to step down from his position as Chief Financial Officer (CFO) of Stille to pursue a new opportunity outside the company.

"I would like to thank Niklas for his significant contributions over the past five years and wish him all the best in his future endeavors. He has played an important role in many key initiatives at Stille, including the successful acquisitions of S&T and Fehling," says Torbjörn Sköld, CEO of Stille.

“In my five years at Stille, the company has achieved strong growth and improved profitability. With this solid foundation in place, it is a natural point to transition leadership to a successor who can continue along the same path. I am very much looking forward to following Stille’s continued success,” says Niklas Carlén

Niklas will remain in his role as CFO and a member of Stille’s management team during his notice period, which runs until the end of July 2025. The recruitment process for his successor has commenced.

Niklas Carlén has served as CFO of Stille since June 2020.

Torshälla den 29 april, 2025.

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-04-29 13:00 CEST.

Contact Details
Torbjörn Sköld
CEO & President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se

About Us
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.

Attachments
Niklas Carlén to Leave is Position as CFO of Stille

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team